Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.66 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.60 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.60 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21998902 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL7821193 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL12430335 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL7824612 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL21999362 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL7822881 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL27501194 | 0.99 | SMN1; SMN2 (0.67) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL7567258 | 0.94 | SMN1; SMN2 (0.69) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL10424495 | 0.92 | SOAT2 (0.74) | SMN1; SMN2NPC1RAB9AHTTMEN1 | |
| SCHEMBL10602602 | 0.92 | SOAT2 (0.74) | SMN1; SMN2NPC1RAB9AHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, SHH | SMN1; SMN2 4775/4885NPC1 423/4885RAB9A 3627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.